인쇄하기

취소

The Green Cross’s ‘Shinbaro’ has been approved for its safety and effectiveness in its Phase 4 clinical trial

Published: 2015-05-11 10:26:26

Updated: 2015-05-11 10:26:26

Green Cross (President Eun-chul Huh) announced on the 7^th that it unveiled the Pharse 4 clinical trial result of the arthritis treatment ‘Shinbaro Cap’ in its poster session at the 2015 Osteoarthritis Research Society International (OARSI) held from the 28^th of the last month to the 3^rd in Seattle, USA.

The Phase 4 clinical trial revealed in the conference was conducted to confirm effectivenes...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.

Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.